lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
product description
5,5-dimethyloxazolidine-2,4-dione
produce name: | 5,5-dimethyloxazolidine-2,4-dione |
alias: | dimethadione; 5,5-dimethyl-2,4-oxazolidinedione; 5,5-dimethyl-1,3-oxazolidine-2,4-dione; 5,5-dipropyl-1,3-oxazolidine-2,4-dione; 3,5-dimethyl-1,3-oxazolidine-2,4-dione |
cas no.: | 4946-14-9 |
molecular weight: | 151.2492 |
structural formula: | |
molecular formula: | c9h12s |
inchi: | inchi=1/c5h7no3/c1-3-4(7)6(2)5(8)9-3/h3h,1-2h3 |
introduction: |
molecular formula: c5h7no3 melting point: 74-79 |
application: | pharm and intermediates |
superiority: |
hubei jusheng technology co., ltd., is a global chemical industry manufacturers and suppliers of parmaceuticals and intermediates in china. the yearly production capacity is 50000mt,80% for export.we have arofessinal export team. both by air and by sea,we ensure that we meet the customer expectations with promptness. |